Patent Number | Patent Title | Publication Date | Inventor | Link |
WO2008084069A1 | A METHOD FOR EXPANDING MONOCYTES | 17.07.2008 | M. Sieweke et al. | |
WO2008083931A1 | USE OF A TAILORED RECOMBINASES FOR THE TREATMENT OF RETROVIRAL INFECTIONS | 17.08.2008 | F. Buchholz et al. | |
WO2012072268A8 | ANTI CD4 ANTIBODIES TO PREVENT IN PARTICULAR GRAFT -VERSUS - HOST - DISEASE (GVHD) | 28.03.2013 | S. Fricke et al. | |
EP2383333A1 | METHOD FOR PRODUCING POLARIZED RETINAL PROGENITOR CELLS FROM PLURIPOTENT STEM CELLS AND THEIR DIFFERENTIATION INTO RETINAL PIGMENT EPITHELIUM CELLS | 27.05.2015 | E. Tanaka et al. | |
WO2017050884A1 | A METHOD FOR HIGH LEVEL AND STABLE GENE TRANSFER IN LYMPHOCYTES | 30.03.2017 | M. Hudecek, Z. Ivics | |
WO2018020008 | DEVICE FOR ISOLATING STEM CELLS FROM FETAL TISSUES | 01.02.2018 | M. Rüdiger et al. | |
WO2019063747A1 | MUTATED ADENO-ASSOCIATED VIRAL CAPSID PROTEINS FOR CHEMICAL COUPLING OF LIGANDS, NANOPARTICLES OR DRUGS VIA THIOETHER BINDING AND PRODUCTION METHOD THEREOF | 04.04.2019 | H. Büning et al. | |
WO2020104676A1 | ARTIFICIAL HLA-POSITIVE FEEDER CELL LINES FOR NK CELLS AND USES THEREOF | 28.05.2020 | A. Temme | |
WO2022194929A1 | EX-VIVO PROLIFERATION OF HUMAN PHAGOCYTIC CELLS | 22.09.2022 | M. Sieweke et al. | |
WO2022194930A1 | HUMAN MACROPHAGES RESISTANT TO TUMOR-INDUCED REPOLARIZATION | 22.09.2022 | M. Sieweke et al. | |
WO2023083760A1 | KOALA RETROVIRUS ENVELOPE GLYCOPROTEINS AND USES THEREOF | 19.05.2023 | D. Schmiedel, S. Fricke, U. Köhl et al. | |
WO2023084099A1 | SITE-SPECIFIC RECOMBINASES FOR EFFICIENT AND SPECIFIC GENOME EDITING | 19.05.2023 | F. Buchholz et al. | |
WO2023094436A1 | PLACENTAL MACROPHAGES FOR CELL THERAPY | 01.06.2023 | M. Sieweke et al. | |
WO2023169899A1 | TARGETED DELIVERY OF OLIGONUCLEOTIDES INTO EUKARYOTIC CELLS USING HYBRID MALTOSE/CYCLODEXTRIN POLYPLEXES | 14.09.2023 | A.Temme et al. | |
WO2024017998A1 | M-CSF FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL INFECTIONS IN STATES OF IMMUNOSUPPRESSION | 25.01.2024 | M. Sieweke et al. | |
WO2024056738A1 | ALLOGENEIC HUMAN MACROPHAGES FOR CELL THERAPY | 20.03.2024 | M. Sieweke et al. | |
WO2024180092A1 | DESIGNER RECOMBINASE FOR THE PRECISE EXCISION OF HTLV-1-PROVIRUS | 04.09.2024 | F. Buchholz et al. | |
WO2024218137A1 | NOVEL RECOMBINASE ENZYMES FOR SITE-SPECIFIC DNA-RECOMBINATION | 24.10.2024 | F. Buchholz et al. | |
WO2024227911A2 | HIGHLY ACTIVE CRISPR BASE EDITORS OBTAINED THROUGH CAS-ASSISTED SUBSTRATE-LINKED DIRECTED EVOLUTION (CASLIDE) | 07.11.2024 | F. Buchholz et al. | |
WO2025083040A1 | CONDITIONED DNA MODIFYING ENZYME COMPRISING HETEROLOGOUS DNA BINDING DOMAIN | 24.04.2025 | F. Buchholz et al. | |
WO2025252950A1 | METHOD FOR PRODUCING SPACER-SPECIFIC DNA RECOMBINING ENZYMES | 11.12.2025 | F. Buchholz et al. |
